Company intelligence / Profile preview

Royal Pharma

Ownership: Private
Development stage: Commercial

Overview

Royal Pharma is a name used by several companies in the pharmaceutical sector. The most prominent is an India-based manufacturer specializing in advanced intermediates and active pharmaceutical ingredients (APIs), operating USFDA-approved and WHO GMP-certified facilities. They focus on custom synthesis, organic chemistry, and supply to global pharma companies. There is also an Egyptian company under this name focused on veterinary pharmaceuticals, as well as other unrelated trading/distribution businesses using similar names.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

7 assets

imbruvica

Commercial

Indications: Oncology

6 more assets in the full pipeline.

Request access →

Partnerships

Not publicly disclosed; collaborates with multinational pharma companies as clients

Beyond the preview

Go deeper on Royal Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Royal Pharma.

Explore the full profile